Weiguo Zhou
Hefei, 230022, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Integrative analysis of machine learning and single-cell sequencing identifies IGHG1 as a therapeutic target for epimedium in diabetes-gastric cancer comorbidity.
Journal: Biochemical and biophysical research communications
Published: April 30, 2026
Mechanism of triptolide in the treatment of gastric cancer with diabetes through JAK2/STAT3 pathway.
Mechanism of triptolide in the treatment of gastric cancer with diabetes through JAK2/STAT3 pathway.
Journal: European journal of pharmacology
Published: July 21, 2025
Validate the Treatment of Crohn's Disease with Chaihu Guizhi Decoction Through Network Pharmacology, Molecular Dynamics Simulation, and in vivo Experiments.
Journal: Journal of inflammation research
Published: June 03, 2025
Machine Learning and Mendelian Randomization Identify Six Cell Death-Related Genes Driving Ulcerative Colitis Progression and Treatment Response.
Journal: Journal of inflammation research
Published: April 23, 2025
Prediction of potential targets of aloe-emodin in the treatment of hepatocellular carcinoma using network pharmacology combined with bioinformatics.
Journal: Discover oncology
Published: December 09, 2024
Exploring the active ingredients of Banzhilian and its mechanism of action on diabetic Gastric cancer based on network pharmacology.
Journal: Scientific reports
Published: December 07, 2024
Mechanistic study of quercetin in the treatment of hepatocellular carcinoma with diabetes via MEK/ERK pathway.
Journal: International immunopharmacology
Published: July 07, 2024
Forefronts and hotspots evolution of the nanomaterial application in anti-tumor immunotherapy: a scientometric analysis.
Journal: Journal of nanobiotechnology
Published: June 20, 2023
Validation of quercetin in the treatment of colon cancer with diabetes via network pharmacology, molecular dynamics simulations, and in vitro experiments.
Journal: Molecular diversity
Published: January 09, 2023
A novel signature based on CeRNA and immune status predicts prognostic risk and drug sensitivity in gastric cancer patients.
Journal: Frontiers in immunology
Published: May 23, 2022
Development and Validation of a Pyroptosis-Related Signature for Predicting Prognosis in Hepatocellular Carcinoma.
Journal: Frontiers in genetics
Published: October 25, 2021
Showing 1-11 of 11
Last Updated: 09/26/2026